Pharmacist intervention may help identify potential opioid abuse early

Concurrent drug utilization review catches opioid abuse upstream

July 21, 2016

Concurrent drug utilization review (DUR) may cast wider net for catching potential opioid abuse upstream

A pharmacist intervention (DUR) may impact potential opioid misuse and abuse. This study identified at-risk members at the time they submit their opioid prescription. A soft edit (point of service) intervention delayed or altered claims for 42% of the members in the study.

Impact of a Concurrent Drug Utilization Review Edit Designed to Curb Opioid Misuse (Spring 2016)

Related research

Scientific presentations

August 1, 2021

Prime’s analytics uncovers the hidden ups and downs behind the flat drug trend for MS DMDs

Insights from integrated medical and pharmacy claims show a big upswing in one…

Scientific presentations

June 21, 2021

Break autoimmune (AI) into indication-specific info for actionable strategy

Prime uses integrated medical and pharmacy data and breaks down largest drug category…

Scientific presentations

April 21, 2021

Prime links changes in adherence rates with total cost of care

Prime’s unique study of Medicare Advantage members uses integrated benefits data to show…